Literature DB >> 10562692

Familial mixed tumors of the parotid gland.

M S Ahn1, G M Hayashi, R L Hilsinger, A K Lalwani.   

Abstract

BACKGROUND: The most common neoplasm of the parotid gland is the pleomorphic adenoma. The familial occurrence of such tumors arising within the parotid gland is rare, with only 3 previous reports in the literature. Bilateral synchronous pleomorphic adenomas of the parotid gland are also uncommon. We report 2 siblings with pleomorphic adenomas of the parotid gland, 1 of whom had bilateral synchronous mixed tumors. Patients and Methods Chromosomal analysis of tumor cells from the sibling with bilateral adenomas revealed the translocation t(3;12)(p21;q15). Chromosome 12q breakpoints have previously been identified in a wide variety of solid tumors including pleomorphic adenomas of the parotid gland.
CONCLUSIONS: We discuss bilateral mixed tumors, familial parotid tumors, and the potential for a genetic predisposition for the recurrence of such parotid tumors, as suggested by characteristic chromosomal translocations associated with mixed tumors. Copyright 1999 John Wiley & Sons, Inc. Head Neck 21: 772-775, 1999.

Entities:  

Mesh:

Year:  1999        PMID: 10562692     DOI: 10.1002/(sici)1097-0347(199912)21:8<772::aid-hed14>3.3.co;2-g

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

1.  The role of insulin-like growth factor I-II receptor on development of pleomorphic adenoma.

Authors:  Ibrahim Arslan; Erol Keles; I Hanifi Ozercan; Mehmet Tokdemir; Turgut Karlidag; Irfan Kaygusuz; Orkun Eroglu; Koray Yuksel; Sinasi Yalcin
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-06-17       Impact factor: 2.503

2.  Apparent diffusion coefficient mapping of the normal parotid gland and parotid involvement in patients with systemic connective tissue disorders.

Authors:  Rahul R Patel; Ruth C Carlos; Mehran Midia; Suresh K Mukherji
Journal:  AJNR Am J Neuroradiol       Date:  2004-01       Impact factor: 3.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.